Core Viewpoint - PulteGroup Inc. is expected to report its fourth-quarter 2025 results on January 29, with anticipated declines in both earnings per share (EPS) and total revenues compared to the previous year [1][2] Revenue Performance - The Zacks Consensus Estimate for PulteGroup's fourth-quarter EPS has decreased to $2.78, reflecting a 20.6% decline from the year-ago EPS of $3.50 [2] - Total revenues are projected at $4.31 billion, indicating a 12.4% year-over-year decline, primarily due to ongoing affordability challenges in the housing market and high mortgage rates [2][3] Home Closings and Segment Performance - Home closings are expected to be between 7,200 and 7,600 units, down from 8,103 units a year ago, with a predicted decline of 8.3% year over year to 7,429 units [4] - Homebuilding revenues are forecasted to decrease 12.2% year over year to $4.22 billion, while Financial Services revenues are expected to drop 4.4% to $110 million [5] Pricing and Margins - The average selling price (ASP) for the quarter is anticipated to be between $560,000 and $570,000, down from $581,000 a year ago, with a predicted decrease of 3.3% year over year to $561,700 [6] - Home sales gross margin is expected to be between 25.5% and 26%, down from 27.5% in the previous year, with SG&A expenses projected to rise to between 9.5% and 9.7% [9] Orders and Backlogs - Net new orders are expected to decline by 0.9% year over year to 6,114 units, while total backlog is projected to decrease by 15.6% to 8,572 units, with a total backlog value of $5.49 billion, down 15.5% year over year [10] Earnings Prediction - The model does not predict an earnings beat for PulteGroup this quarter, with an Earnings ESP of +2.10% and a Zacks Rank of 4 (Sell) [11]

Core Insights - Lockheed Martin (LMT) is expected to report fourth-quarter 2025 results on January 29, 2026, with revenue estimates at $19.83 billion, reflecting a 6.5% increase year-over-year, while earnings per share (EPS) are projected at $6.24, indicating an 18.6% decline from the previous year [1][5]. Revenue Estimates - The Zacks Consensus Estimate for current quarter revenue is $19.83 billion, with a year-over-year growth estimate of 6.48% [2]. - The revenue for the next quarter is estimated at $18.71 billion, with a growth estimate of 4.17% [2]. - For the current year, total revenue is projected at $74.55 billion, with a growth estimate of 4.94%, and for the next year, it is expected to reach $77.80 billion, with a growth estimate of 4.36% [2]. Earnings Estimates - The Zacks Consensus Estimate for EPS in the current quarter is $6.24, reflecting a year-over-year decline of 18.64% [3]. - The next quarter's EPS estimate is $7.13, with a slight decline of 2.06% expected [3]. - For the current year, EPS is projected at $21.90, indicating a significant decline of 23.08%, while the next year’s EPS is expected to rise to $29.55, reflecting a growth of 34.93% [3]. Performance Metrics - LMT has consistently beaten the Zacks Consensus Estimate in the past four quarters, with an average surprise of 13.29% [4]. - The company has an Earnings ESP of -9.36% and a Zacks Rank of 3, indicating a neutral outlook for the upcoming earnings report [6]. Key Growth Drivers - Increased production of F-35 jets, missiles, helicopters, and space programs is expected to drive revenue growth [5][8]. - The Aeronautics segment is likely to benefit from higher sales volume due to increased production contracts for the F-35 jet program [8]. - The Missiles and Fire Control segment is anticipated to see improved sales performance from tactical and strike missile programs [8]. Challenges Impacting Earnings - Higher tariff-related costs and program charges are expected to pressure earnings despite increased sales volume [10]. - Losses from helicopter contracts and charges related to classified programs are also anticipated to negatively impact the bottom line [11]. Stock Performance and Valuation - LMT's stock has increased by 41.6% over the past six months, outperforming the aerospace-defense industry growth of 8.6% [12]. - The forward 12-month price-to-sales (P/S) ratio for LMT is 1.76X, which is lower than the industry average of 2.72X, suggesting a more favorable valuation compared to peers [13]. Long-term Outlook - The company is well-positioned for long-term growth due to steady demand for core defense programs and a strong order backlog [15]. - Continued contract wins across key platforms, rising international demand, and supportive U.S. defense spending are expected to enhance revenue visibility [15][18]. - However, geopolitical factors and potential supply-chain disruptions present uncertainties that could affect performance [18].

Core Insights - The fourth-quarter 2025 earnings season is underway, with a focus on the oil and energy sector facing macroeconomic uncertainty and commodity price volatility [1] - A few energy companies are positioned to exceed earnings expectations, potentially leading to stock price boosts and investment opportunities [1] Oil and Gas Price Movements - West Texas Intermediate crude oil prices averaged $59.64 per barrel in Q4 2025, down from $70.69 the previous year, due to global oversupply and sluggish demand growth [3] - OPEC+ nations began unwinding production cuts in September, increasing output alongside steady non-OPEC supply, resulting in inventory builds of up to 2 million barrels per day [3] - Natural gas prices at Henry Hub averaged $3.75 per million British thermal units, up from $2.44 the previous year, driven by colder winter weather, high LNG exports, and increased consumption from data centers [5] Identifying Potential Market Beaters - Research indicates that stocks with a positive Earnings ESP and a Zacks Rank of 1, 2, or 3 have a 70% chance of beating earnings expectations [7] - Earnings ESP is a proprietary tool that measures the percentage difference between the Most Accurate Estimate and the Zacks Consensus Estimate [7] Company Highlights - **Imperial Oil Limited (IMO)**: Expected to report earnings of $1.40 per share, a 17.16% decrease from the prior year, but has a 1.79% Earnings ESP and a strong track record of exceeding estimates [10] - **ExxonMobil Corporation (XOM)**: Anticipated to post earnings of $1.64 per share, down 1.8% year over year, with a 2.29% Earnings ESP and a history of 5.71% average earnings surprises [12] - **Patterson-UTI Energy, Inc. (PTEN)**: Set to report earnings of 12 cents per share, flat year over year, with a notable 19.15% Earnings ESP and an average surprise of 17.5% [13] - **Helmerich & Payne, Inc. (HP)**: Expected to report earnings of 51 cents per share, a 15% drop from the prior year, but with a 14.85% Earnings ESP and a history of positive earnings surprises [14]

Core Viewpoint - LyondellBasell Industries N.V. (LYB) is expected to report its fourth-quarter 2025 results on January 30, 2026, with anticipated challenges due to seasonality, reduced operating rates, and increased feedstock costs [1][7]. Revenue Estimates - The Zacks Consensus Estimate for LYB's fourth-quarter consolidated revenues is $6,984.4 million, indicating a year-over-year decline of 26.5% [4]. - For the Olefins and Polyolefins – Americas division, the revenue estimate is $2,536 million, reflecting a 7.9% decrease year-over-year [4]. - The Olefins and Polyolefins – Europe, Asia & International division is estimated at $2,378 million, suggesting a 3.8% decline from the previous year [4]. - The Advanced Polymer Solutions segment is expected to generate $837 million in revenue, representing a 1.5% increase year-over-year [5]. - The Intermediaries and Derivatives segment's revenue estimate is $2,203 million, indicating a 6.5% decrease from last year [8]. - The Technology segment's revenue is pegged at $137 million, reflecting a 21.3% decline year-over-year [8]. Factors Impacting Performance - Lower operating rates and seasonal factors are anticipated to negatively affect volumes and margins, with North American olefins and polyolefins assets expected to operate at 80% capacity, European facilities at 60%, and Intermediates & Derivatives assets at 75% [9]. - The company plans to idle one of its PO/SM units in Channelview and one of its crackers in Germany, which is likely to impact production volumes and margins [10]. - Year-end seasonality, reduced demand, and customer inventory reductions are expected to weigh on volumes in the Olefins and Polyolefins – Americas unit, with weak industrial and consumer demand in Europe [10]. - Higher natural gas and feedstock costs are likely to exert pressure on margins in both North America and Europe [11]. - The Advanced Polymer Solutions segment is facing challenges due to lower demand in the automotive sector, which is expected to continue affecting this segment [12]. Earnings Prediction - The model does not predict a definitive earnings beat for LyondellBasell this quarter, as the combination of a positive Earnings ESP of +1.85% and a Zacks Rank of 4 (Sell) does not support an earnings beat [13][14].

Core Insights - Phibro Animal Health Corp. (PAHC) is set to announce its second-quarter fiscal 2026 results, with expectations of continued strong performance based on previous earnings trends [1][3]. Group 1: Financial Performance - In the last reported quarter, PAHC achieved adjusted earnings per share (EPS) of 73 cents, exceeding the Zacks Consensus Estimate by 23.7% [1]. - The Zacks Consensus Estimate for second-quarter revenues is $357 million, reflecting a 15.4% increase year-over-year, while the EPS estimate stands at 69 cents, indicating a 27.8% growth from the previous year [2][7]. Group 2: Business Segments - The Animal Health segment is expected to maintain momentum, driven by the strong performance of the Medicated Feed Additives (MFA) portfolio, along with gains in Nutritional specialties and Vaccines [4]. - Nutritional Specialties are anticipated to see increased net sales due to higher demand for microbial and companion animal products, bolstered by the launch of Restoris piezoelectric dental gel [5]. - Vaccine sales are projected to benefit from growth in poultry products in Latin America and increased international demand, with an overall expected increase of 21.4% in Animal Health sales year-over-year [6]. - The Mineral Nutrition segment may experience an 8.7% decline in sales year-over-year, influenced by fluctuating customer buying patterns and seasonal variability [8]. - Performance Products are forecasted to grow by 20.2% year-over-year, driven by higher demand for ingredients used in personal care products [9]. Group 3: Strategic Initiatives - Phibro's company-wide initiative, Phibro Forward, aims to unlock additional revenue growth and cost savings, enhancing operational discipline and innovation [10].

Core Insights - Boston Scientific (BSX) is expected to report its fourth-quarter 2025 results on February 4, with earnings per share (EPS) anticipated at 78 cents, reflecting an 11.4% growth year-over-year, and revenues projected at $5.27 billion, indicating a 15.4% increase from the previous year [1][2]. Group 1: Financial Performance - The Zacks Consensus Estimate for BSX's revenues is set at $5.27 billion, which represents a 15.4% increase compared to the same quarter last year [2]. - The consensus for earnings is pegged at 78 cents per share, indicating an 11.4% growth from the year-ago quarter [2]. - BSX has consistently beaten earnings estimates in the past four quarters, with an average surprise of 7.36% [1]. Group 2: Business Segment Performance - The MedSurg division is expected to maintain strong sales momentum, with revenues estimated at $1.80 billion, suggesting an 11.4% year-over-year increase, driven by the Endoscopy and Urology businesses [4][7]. - The Cardiovascular segment is projected to see a 17.5% increase in revenues to $3.46 billion, supported by the uptake of WATCHMAN and FARAPULSE products [9][14]. - The Neuromodulation segment is anticipated to grow, bolstered by the Pain franchise and the acquisition of Nalu Medical, which expands BSX's portfolio in peripheral nerve pain [6]. Group 3: Market Developments - The Endoscopy business within MedSurg is benefiting from the Axios platform and the adoption of innovative technologies like OverStitch and Mantis clip [4]. - The Cardiovascular business is expected to perform well due to strong growth in coronary therapies, particularly from the AGENT Drug-Coated Balloon and the WATCHMAN FLX Pro device's launch in China [10][11]. - The Peripheral Interventions unit is likely to continue its growth trend, despite challenges in the Chinese market, with strong performance in Interventional Oncology & Embolization [13].

Core Insights - The retail REIT sector is showing signs of stabilization and improvement, with expectations to surpass Q4 2025 earnings estimates due to steady consumer demand and limited supply growth [2][4][6] Retail REIT Performance - Key retail REITs such as Simon Property Group, Regency Centers, Kimco Realty, and Federal Realty Investment Trust are set to report their Q4 results, reflecting the market conditions from late 2025 [3][4] - Cushman & Wakefield's report indicates a positive net absorption of approximately 3.4 million square feet in Q4 2025, marking the strongest quarterly improvement since Q4 2023 [5] Market Conditions - National retail vacancy rates are at 5.7%, indicating tight conditions compared to historical norms, with limited new supply stabilizing occupancy rates [4][6] - Retail real estate fundamentals are expected to maintain steady performance, with vacancy rates projected to remain below 6% into 2026 and rent growth anticipated in the 2-2.5% range [6] Company-Specific Insights - **Simon Property Group**: Expected to report revenues of $1.63 billion for Q4 2025, reflecting a 2.84% year-over-year increase, with a focus on high-quality assets and omnichannel integration [10][11] - **Regency Centers**: Anticipated to report revenues of $398.94 million, a 7.09% increase year-over-year, supported by a well-located portfolio and strong demand for grocery-anchored shopping centers [12][13] - **Kimco Realty**: Projected revenues of $537.59 million for Q4 2025, indicating a 2.32% year-over-year increase, benefiting from a diverse tenant base and focus on mixed-use developments [15][16] - **Federal Realty**: Expected to report revenues of $328.96 million, a 5.63% increase year-over-year, driven by improving demand for premium retail assets and strategic acquisitions [18][19]

Core Viewpoint - The Hartford Insurance Group, Inc. (HIG) is expected to report its fourth-quarter 2025 results on January 29, 2026, with earnings estimated at $3.17 per share and revenues of $5.1 billion, reflecting year-over-year growth [1][2]. Earnings Estimates - The fourth-quarter earnings estimate has seen two upward revisions with no downward movements in the past week, indicating a projected year-over-year increase of 7.8% in earnings and 7.4% in revenues [2]. - The Zacks Consensus Estimate for the current year's revenues is $19.9 billion, representing a 9.1% year-over-year increase, while the EPS estimate is $12.54, suggesting a 21.8% rise year-over-year [4]. Estimate Trends - The earnings estimates for the upcoming quarters have shown a positive trend, with the current estimate for Q1 at $3.17, up from $3.09 two months ago, indicating a 2.59% increase [3]. Business Segments Performance - The Business Insurance segment is expected to report earned premiums of $3.6 billion, contributing to a 6% rise in overall net premiums earned, projected at $6.2 billion [6][7]. - The Personal Insurance segment is anticipated to achieve earned premiums of $946.7 million, reflecting a 4.5% increase year-over-year, driven by renewal price increases and favorable net rates [8]. - The Employee Benefits business is projected to generate revenues of $1.8 billion, marking a 2.8% increase from the previous year, supported by favorable mortality trends [9]. Margin Pressures - Despite the expected revenue growth, margins may be pressured by higher operating costs and ongoing investments in digital capabilities, which could impact overall profitability [10].

Core Viewpoint - Wayfair is positioned to potentially continue its earnings-beat streak in the upcoming report, having surpassed earnings estimates significantly in the last two quarters [1]. Earnings Performance - In the last reported quarter, Wayfair achieved earnings of $0.7 per share, exceeding the Zacks Consensus Estimate of $0.46 per share by 52.17% [2]. - In the previous quarter, Wayfair's earnings were $0.87 per share against an expected $0.36 per share, resulting in a surprise of 141.67% [2]. Earnings Estimates - There has been a favorable change in earnings estimates for Wayfair, with a positive Zacks Earnings ESP of +2.81%, indicating bullish sentiment among analysts regarding the company's earnings prospects [4][7]. - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) suggests a high likelihood of another earnings beat [4][7]. Predictive Metrics - Research indicates that stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have a nearly 70% chance of producing a positive surprise [5]. - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions [6].

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Asbury Automotive Group (ABG) . This company, which is in the Zacks Automotive - Retail and Whole Sales industry, shows potential for another earnings beat.This auto dealership chain has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two ...